(Q43233300)

English

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

scientific article published in December 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Kazuhiro Kitajima

1

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Koji Murakami

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Erena Yamasaki

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Yasushi Kaji

4

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Mitsugi Shimoda

5

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Keiichi Kubota

6

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Narufumi Suganuma

7

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Kazuro Sugimura

8

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

publication date

1 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Molecular Imaging and Biology

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

452-459

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgery for recurrent pancreatic ductal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical role of FDG PET in evaluation of cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical palliation in patients with pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of positron emission tomography in the management of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-small cell lung cancer: dual-modality PET/CT in preoperative staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combined PET/CT scanner for clinical oncology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19949988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11307-009-0271-7

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43233300&oldid=2205890138"